FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • July 25th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of the 24th day of July, 2019, by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”) and SETH C. RENO (the “Executive”).
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • July 25th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • New York
THIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into as of July 23, 2019, (the “Effective Date”), by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation having an address at 17199 N Laurel Park Dr., Suite 401 Livonia, MI 48152, United States (“Gemphire”) and BEIJING SL PHARMACEUTICAL CO., LTD., a company organized under the laws of China, having an address at Bitongyuan Building 1, 69 Fushi Road, Beijing 100049, China (“Beijing SL”). Gemphire and Beijing SL may be referred to herein individually as a “Party” or collectively as the “Parties”.
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • July 25th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of the 24th day of July, 2019, by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”) and STEVE GULLANS (the “Executive”)
VOTING AGREEMENTVoting Agreement • July 25th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware
This VOTING AGREEMENT (this “Agreement”) is entered into as of July , 2019, among NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Gemphire Therapeutics Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (the “Stockholder”) of the Company.
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • July 25th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of the 24th day of July, 2019, by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”) and CHARLES L. BISGAIER (the “Executive”).
